Actos pioglitazone HCI

You've taken Actos Pioglitazone HCI with Type 2 diabetes. You've been diagnosed with bladder cancer.

 

You have the right to know if you are eligible for compensation. 

 

CALL TODAY to get your case started.
(800) 600- 6014

You've taken Actos Pioglitazone HCI with Type 2 diabetes. You've been diagnosed with bladder cancer.

You have the right to know if you are eligible for compensation. 

Start your Free Consultation

* Name:

* Email:

* Phone:

* Case Details:

*Required Fields

HELP OTHERS

Spread the word so that others, who have suffered from bladder cancer, can understand their rights.

Taking Actos has been found to increase the risk of bladder cancer by 40%.

It is alleged that Takeda Pharmaceuticals, (the maker of Actos pioglitazone HCI, also known as duetact, actoplus met, and actoplus met XR) was negligent in testing and developing Actos and they had knowledge of the bladder cancer risk associated with the drug.  

Takeda announced, in April 2015, that it would pay up to $2.4 billion to settle Actos lawsuits.

Medical expenses and missed wages could be recovered if you took Actos before December of 2011 and were subsequently diagnosed with bladder cancer.  

 

At Goldberg Attorneys, we truly understand how devastating bladder cancer can be.  Our law firm is here to help you.  Call us today to find out if you have claim. 

CALL TODAY to get your case started.
(800) 600- 6014

Valsartan

Valsartan

Have you taken Valsartan for High Blood Pressure?

If you have taken Valsartan for at least 30 consecutive days or more from 2014 to present, you should know some forms of the medication have been found to contain cancer-causing substances.

Taking Valsartan for High Blood Pressure?

Some forms of the medication have been found to contain cancer-causing substances.

Have you been diagnosed with any of the following conditions?

 • Liver Cancer 

 Colorectal Cancer 

 Bladder Cancer

 Pancreatic Cancer

If so, and you have been taking Valsartan, set up an appointment to talk with someone about a case review today.   

 

CALL TODAY to get your case started.

(800) 600- 6014

Start your Free Consultation

* Name:

* Email:

* Phone:

* Case Details:

*Required Fields

At Goldberg Attorneys, we truly understand the impact of defective drugs. Our law firm is here to help you. Call us today to find out if you have claim.

CALL TODAY to get your case started.

 (800) 600- 6014

What is Valsartan?

Valsartan, is a blood pressure and heart medication. This chemical is a known carcinogen. Several drug companies have recalled their medications containing Valsartan. Check this Valsartan recall list for the specific drugs that have been recalled.

Why is Valsartan defective?

It has been determined that some medications containing Valsartan are contaminated with the cancer-causing substances N-nitrosodimethylamine (NDMA) and/or N-Nitrosodiethylamine (NDEA). The contaminated batches found were produced by the Chinese company Zhejiang Huahai Pharmaceuticals and the Indian company Hetero Labs Limited. 

Symptoms of overexposure to NDMA include:

• Headaches

• Fever

Nausea

Jaundice

Vomiting               

Abdominal Cramps

Enlarged Liver

Dizziness

Reduced function of the liver, kidneys, and lungs

The FDA reminds patients taking medication containing Valsartan to continue taking their current medicine until their doctor or pharmacist provides a replacement or alternative treatment option. 

Taxotere®

Taxotere®

Permanent Hair Loss And Taxotere

You won your battle with breast cancer,
and yet every day you face a reminder of what you lost.

Permanent Hair Loss And Taxotere

You won your battle with breast cancer,
and yet every day you face a reminder of what you lost.

 

Are you, a family member, or a friend dealing with permanent hair loss after surviving breast cancer?

 

Were you treated with chemotherapy drug Taxotere®?

 

You should know, Taxotere® may be the cause of permanent hair loss.

CALL TODAY to get your case started.
(800) 600- 6014

Start your Free Consultation

* Name:

* Email:

* Phone:

* Case Details:

*Required Fields

What is Taxotere®?

Taxotere®, generically named Docetaxel, is an anti-cancer chemotherapy drug approved for the treatment of different kinds of cancer, including breast cancer. Taxotere® is manufactured by Sanofi™ and was first approved by the U.S. Food and Drug Administration (FDA) in 1996 for the treatment of metastic breast cancer.

Why Taxotere® Is Defective?

Although, temporary hair loss may be a possible side effect of chemotherapy, an alarming number of research studies show that Taxotere® can be linked to permanent hair loss. Researchers at the National Cancer Conference reported in 2014 that permanent hair loss was a side effect in 10-15% of chemotherapy patients who took Taxotere®.

Furthermore, a study by the Annals of Oncology, noted Taxotere®’s devastating effect on a patient’s quality of life.

At Goldberg Attorneys, we truly understand how devastating permanent hair loss can be.  Our law firm is here to help you.  Call us today to find out if you have claim. 

LEARN MORE

about Taxotere® and its impacts today.
Talcum Powder & Ovarian Cancer

Talcum Powder & Ovarian Cancer

Is there a link to Talcum Powder and Ovarian Cancer?

Baby Powder Lawsuits Filed for Ovarian Cancer

It smells nice, evokes memories of babyhood, and babies, but talcum powder has more recently been found to cause ovarian cancer when used by women for hygiene. Johnson & Johnson, a major manufacturer of talc-based baby powder and body powder, has been accused of failing to warn consumers of the risks of talcum powder. According to a recent Harvard study, women who use talcum powder in the genital or perineal region could be at a 41% higher risk for developing ovarian cancer.

“As many as 10,000 women develop ovarian cancer each year as a result of baby powder use,” says Harvard epidemiologist Dr. Daniel Cramer. Ovarian cancer is a serious disease anticipated to result in more than 14,000 deaths annually, in the United States.

Is there a link to Talcum Powder and Ovarian Cancer?

Baby Powder Lawsuits Filed for Ovarian Cancer

It smells nice, evokes memories of babyhood, and babies, but talcum powder has more recently been found to cause ovarian cancer when used by women for hygiene. Johnson & Johnson, a major manufacturer of talc-based baby powder and body powder, has been accused of failing to warn consumers of the risks of talcum powder. According to a recent Harvard study, women who use talcum powder in the genital or perineal region could be at a 41% higher risk for developing ovarian cancer.

“As many as 10,000 women develop ovarian cancer each year as a result of baby powder use,” says Harvard epidemiologist Dr. Daniel Cramer. Ovarian cancer is a serious disease anticipated to result in more than 14,000 deaths annually, in the United States.

The first talcum powder ovarian cancer lawsuit was won against Johnson & Johnson in Federal Court in 2013. Johnson and Johnson is a long-time trusted household name, but their reputation has diminished due to problems with products such as Tylenol, DePuy hip replacement parts, and now, talcum powder.

See below for more detailed studies, call us at (800) 600-6014.  Let us help you decide if you are one of the many people who are at risk from using talcum powder.

If you or a loved one were diagnosed with ovarian cancer and have a history of talcum powder use, then you may be eligible for financial compensation. It is not your fault. If you got sick from using a common and trusted toiletry product, we want to help you. Call Goldberg Attorneys right away at (800) 600-6014.

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

A jury ordered Johnson & Johnson to pay $55 million to a woman who claims talc in the company’s baby powder caused her ovarian cancer.

On Monday, a jury in St. Louis, awarded Gloria Ristesund $5 million in damages and $50 million in punitive damages, Reuters reported.

The verdict comes months after a jury ordered the company to pay $72 million to the family of an Alabama woman who died from ovarian cancer allegedly caused by using the company’s Baby Powder and other products which contained talc.

IVC Filter

IVC Filter

Injured by an IVC Filter?

Since the introduction of IVC filter in 2005, the FDA has received thousands of adverse reports involving these filters. Specifically, it was reported that the IVC filters fragment and migration in the body.

Goldberg Attorneys is filing lawsuits against the makers of the IVC filters for causing serious harm and death to people through out the country.

What is an IVC Filter?

IVC filters are small, cage-like devices that are inserted into the inferior vena cava to capture blood clots and prevent them from reaching the lungs. The inferior vena cava is the main vessel returning blood from the lower half of the body to the heart. IVC filters are frequently placed in patients at risk for pulmonary embolism (a blood clot in the lungs) when anticoagulant therapy cannot be used or is ineffective. IVC filters are designed to be permanent implants although some of these devices may have the option to be removed.

Injured by an IVC Filter?

Since the introduction of IVC filter in 2005, the FDA has received thousands of adverse reports involving these filters. Specifically, it was reported that the IVC filters fragment and migration in the body.

Goldberg Attorneys is filing lawsuits against the makers of the IVC filters for causing serious harm and death to people through out the country.

What is an IVC Filter?

IVC filters are small, cage-like devices that are inserted into the inferior vena cava to capture blood clots and prevent them from reaching the lungs. The inferior vena cava is the main vessel returning blood from the lower half of the body to the heart. IVC filters are frequently placed in patients at risk for pulmonary embolism (a blood clot in the lungs) when anticoagulant therapy cannot be used or is ineffective. IVC filters are designed to be permanent implants although some of these devices may have the option to be removed.

The FDA has received reports of adverse events and product problems associated with IVC filters. Types of reports include device migration, filter fracture, migration, perforation of the IVC, and difficulty removing the device. Some of these events led to adverse clinical outcomes such as:

  • Death
  • Deep vein thrombosis (DVT)
  • Emergency removal of device
  • IVC filter migration
  • Perforation of tissue, vessels and organs
  • Pulmonary embolism
  • Respiratory distress
  • Severe Pain
  • Shortness of breath

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

Removal of an IVC Filter

Unless there is a very good reason to keep the IVC filter in place, the FDA now recommends the removal of retrievable IVC filters.

According to a safety communication posted by the FDA in August of 2010, IVC filters are intended for short-term placement and have caused risks when left in long term including lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.

Despite FDA Warnings, Physicians Were Not Removing the Filters.

Researchers discovered only 58 out of 679 (less than 10%) retrievable IVC filters inserted were actually removed. Other results discovered majority of the filters remained in patients longer than medically necessary with the following results:

  • 3 percent failed attempts at removing the filters
  • 8 percent had venous thrombotic events.

Approximately 25 of those events were pulmonary embolism.

If you or a loved one has had an ICV Filter and experienced complications, please contact or call Goldberg Attorneys (800) 600-6014.

Essure

Essure

Women who chose to undergo a permanent birth control procedure, tend to have full faith it will result in a safe and effective means of preventing pregnancy. What you might not have known is that procedures involving permanent fallopian tube implants such as Essure® have reportedly caused a host of serious side effects and complications in thousands of women ranging from chronic pelvic pain to even death.

ESSURE BIRTH CONTROL DEVICE CAN BREAK OR MIGRATE AFTER INSERTION

ADVERSE EFFECTS INCLUDE:

  • Hysterectomy
  • Surgical Removal
  • Severe Abdominal Pain
  • Miscarriage
  • Ectopic Pregnancy

Women who chose to undergo a permanent birth control procedure, tend to have full faith it will result in a safe and effective means of preventing pregnancy. What you might not have known is that procedures involving permanent fallopian tube implants such as Essure® have reportedly caused a host of serious side effects and complications in thousands of women ranging from chronic pelvic pain to even death.

ESSURE BIRTH CONTROL DEVICE CAN BREAK OR MIGRATE AFTER INSERTION

ADVERSE EFFECTS INCLUDE:

  • Hysterectomy
  • Surgical Removal
  • Severe Abdominal Pain
  • Miscarriage
  • Ectopic Pregnancy

March 4, 2016 – FDA takes action on Essure permanent birth control procedure

On Feb. 29, 2016, 2016, The U.S. Food and Drug Administration released the next steps for Bayer AG’s permanent sterilization device, Essure®, including two multipart actions in effort to provide women and physicians with better information about the potential risks associated with using Essure.

If you have experienced serious problems from an Essure Device, call Goldberg Attorneys, (800) 600-6014, for a free, confidential consultation. You may be entitled to financial compensation.

 

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

Taxotere® old

Act Now Because There Is A Limited Window of Time To Pursue A Legal Case!

If you took the breast cancer medication Taxotere, and experienced permanent hair loss you might be eligible for financial compensation.

**No Need to fill out the long forms, call Goldberg Attorneys to see if you have a claim.**

When a side effect of a drug so devastating as permanent hair loss is purposely hidden from cancer patients and physicians, innocent people become victims…

And the women who have suffered the traumatic consequences of permanent hair loss are now realizing that the drug manufacturer of Taxotere® (Sanofi™) may be to blame…

Sanofi™, maker of popular chemotherapy drug Taxotere®, has been alleged with failing to properly warn of permanent hair loss (alopecia) — in fact, the FDA took action in December 2015 forcing Sanofi™ to warn patients and doctors of permanent alopecia.

 

Why Taxotere® (Docetaxel) Is Defective…

Taxotere® (generically named Docetaxel) is an anti-cancer chemotherapy drug that is classified as a “taxane”, or “plant alkaloid”.

Chemo patients are typically given Taxotere® (made by Sanofi™) or Taxol® (made by Bristol Myers Squibb™) during chemotherapy. However, studies are showing that only Taxotere® has significant risk for permanent alopecia (hair loss) while perhaps being even less effective than the alternative drug, Taxol®.

 

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

Alarming Number of Research Studies Show Taxotere® Linked To Permanent Hair Loss…

Researchers at the National Cancer Conference in 2014 reported that permanent hair loss was a side effect in 10-15% of chemotherapy patients who took Taxotere®, according research conducted by the National Cancer Research Institute (NCRI).

STUDY“Distressing Psychological Consequences in the Patients’ Lives”

A groundbreaking study by the Annals of Oncology concluded that Taxotere® does significantly cause permanent hair loss in females who use the drug in chemotherapy treatment.

The study also noted Taxotere®’s devastating effect on a patient’s quality of life. Something so psychologically distressing as permanent hair loss could certainly hinder a patient’s successful recovery.

“Long term hair loss has a significant impact on quality of survival. This risk should be discussed routinely (as part of the process of informed consent) with all patients embarking upon Taxotere® as a component of management of early breast cancer.” The Clatterbridge Cancer Center Study

Study Finds ZERO Benefits To Taxotere® In Regards To Efficacy…

Compared To Alternative Drug Taxol® Which Doesn’t Have The Risks of Permanent Hair Loss

The New England Journal of Medicine (NEJM) in 2008 published a study of 5,000 women that found that the alternative chemotherapy drug Taxol® showed higherrates of survival than Taxotere® — and did not come with the risks of permanent hair loss.

 

Why Are Doctors Even Using Taxotere?

Because Sanofi™ (maker of Taxotere®) failed to list permanent hair loss as a known risk (FDA forced them to in Dec 2015)so doctors were not fully aware what was causing some patients to have permanent hair loss.

ALSO.. Taxotere® has always been attractive to doctors and pharmacies — NOT because it is more effective, but because it is CHEAPER.

Sanofi™ developed Taxotere® to be a non-natural “synthetic” version of its competitor drug, Taxol®. They also made it twice as toxic, which many researchers believe is the reason why hair follicles become permanently damaged during treatment.

 

“The one side effect possibly most dreaded by the patient is alopecia. Yet, we have always told our female patients don’t worry [hair] will always come back. This last statement may not be true.”

— Dr. Scot Sedlacek, Oncologist at Rocky Mountain Cancer Centers

Why The Manufacturer of Taxotere®(Sanofi™) FAILED Patients and Doctors…

Sanofi™ (the drug manufacturer) has known about Taxotere®’s risks concerning permanent hair loss for many years, but utterly FAILED to put a proper warning on its drug.

Meanwhile, doctors have been treating chemo patients with Taxotere® and unknowingly telling patients their ‘hair will return’… NOT knowing that roughly 1 in 10 patients will NEVER see their hair again.

This Is An Issue of Informed Consent!

Why Patients Have A Right To Be Warned of Risks And Choose A Safer Drug…

A “Patients Bill of Rights” was adopted by the U.S. Advisory Commission on Consumer Protection and Quality in the Health Care Industry…

As the American Cancer Society states, “You have the right to know your treatment options and take part in the decisions about your care.”

“So why aren’t breast cancer patients being informed of the risk of this psychologically devastating side effect?The undisclosed link between Taxotere® and permanent hair loss is not about vanity. It’s about full and honest disclosure. And it’s about a patient’s right to make fully informed decisions about their treatment… It’s time to take off the rose-colored glasses and have a cold hard look at the facts.” A Head of Our Time (Hair Loss Support Group)

 

FDA ISSUES WARNING LETTER TO SANOFI™ ABOUT TAXOTERE®

FDA Found Marketing of Taxotere® To Be False or Misleading Due To Unsubstantiated Superiority ClaimsAnd Overstatement of the Efficacy of Taxotere®

We now know thanks to the New England Journal of Medicine (NEJM) study of 5,000 women that Taxotere® was shown to be less effective in cancer treatment than its American-made competitor drug, Taxol®.

So the FDA warned Sanofi™ that their drug was being marketed to doctors and patients falsely or misleadingly.

FDA WARNS SANOFI™ AGAINTHIS TIME OVER LACK OF WARNING FOR PERMANENT HAIR LOSS…

In December 2015, The FDA warned Sanofi™ (again) that they must add permanent alopecia (hair loss) to their drug warning label.

Up until the FDA forced the warning label to include permanent hair loss, Sanofi®’s label was inappropriate…

“While most patients lose their hair during treatment, hair generally grows back.”

“They absolutely told me my hair will grow back. I will never be well of breast cancer because of this. My life is not over, but my life is drastically changed.”

— Pamela Kirby, 58

There is a hair loss support group that “calls themselves the ‘Taxotears’, and [they] are encouraging women who have lost all their hair to report the adverse events to Sanofi™ and drug watchdog authorities. They are also gently harassing Sanofi™ to draw attention to their plight.”

— From CBS NEWS Article, Sanofi’s Latest Challenge: Women Who Say Its Chemotherapy Left Them Permanently Bald

Lawsuits Are Being Filed Against Sanofi™ By Victims of Taxotere® – Why Permanent Hair Loss Victims Could See Significant Financial Compensation…

As more evidence comes to light about Taxotere®’s risks and Sanofi™’s FDA warnings, hair loss victims are now filing lawsuits seeking financial compensation.

LAWSUIT FILED: In California, a federal lawsuit filed against Sanofi™ alleges that not only did Sanofi™ know of the permanent alopecia risks, but actively tried to hide and conceal these risks while falsely marketing Taxotere® as a more effective chemotherapy drug — which the FDA warned was not true.

“Defendants [preyed] on one of the most vulnerable groups of individuals at the most difficult time in their lives. Defendants obtained billions of dollars in increased revenues at the expense of unwary cancer victims simply hoping to survive their condition and return to a normal life.”

LAWSUIT FILED: In US District Court, Northern District of Ohio, another lawsuit has been filed against Sanofi™ alleging that the drug maker led patients and doctors to believe hair would generally grow back, when they knew otherwise…

“Although alopecia is a common side effect related to chemotherapy drugs, permanent alopecia is not. Defendants, through its publications and marketing material, misled Plaintiff, the public, and the medical community to believe that, as with other chemotherapy drugs that cause alopecia, patients’ hair would grow back.”

 

What To Do If You Experienced Permanent Hair Loss After Being Treated With Taxotere®

The law protects patients from dangerous drugs that can cause serious physical and emotional harm…

If you (or a loved one) were given Taxotere® during chemotherapywhich subsequently resulted in permanent hair loss (alopecia)this may be the most important message you will ever read.

Here is why…

Taxotere® has medically been linked to:

  • Alopecia Areata (patches of hair)
  • Alopecia Totalis (total loss of hair on scalp)
  • Alopecia Universalis (loss of hair over entire body)
  • …and other permanent hair loss

When Drug Manufacturers Fail To Properly Warn of Risks, Innocent Patients Become Victims

As a result of the manufacturer of Taxotere® failing to properly warn patients and doctors of these permanent hair loss (alopecia)risks, you or your loved one likely suffered emotional and physical stress, along with unintended financial burdens.

Why should you suffer and be responsible for the stress caused by a drug manufacturer’s failure to warn you?

As a victim of a drug manufacturer that potentially FAILED to properly warn you of such permanent hair loss with their medication, you may be entitled to what are called “money damages“, which is just a legal term for money awarded from individual lawsuits, settlements and class action lawsuits.

Potential Taxotere® lawsuits are currently being investigated on the grounds that Sanofi™ (maker of Taxotere®)

  • failed to properly warn patients and doctors of the known risk of permanent alopecia
  • attempted to hide or conceal the risk of permanent alopecia
  • promoted Taxotere®’s alleged superiority with no substantiation
  • collaborated in marketing and sales schemes to increase sales of Taxotere®
  • concealed the drug’s increased toxicity compared to other similar drugs
  • used marketing materials that were false or misleading, including unsubstantiated superiority claims and overstatement of drug’s efficacy
  • told patients and doctors hair generally grows back after use of Taxotere®
  • failed to notify the FDA in a timely manner about reports of permanent alopecia

How To Pursue Financial Compensation If You (Or A Loved One) Was Affected…

Our legal team has reviewed the available evidence and our experience tells us that we are in prime position to represent victims effectively who have suffered permanent hair loss, emotional suffering and financial consequences due to the use of Taxotere®.

We are currently accepting cases nationally from all 50 states.

Get A Free Legal Consultation With Our Taxotere® Lawyers Today

For a limited time, our Taxotere® lawsuit lawyers are offering FREE legal consultations to those who may have suffered both physically and emotionally due to permanent alopecia caused by Taxotere®.

This is your opportunity to have a conversation with an experienced attorney who can answer all your questions and help you determine if you are eligible to pursue financial compensation.

Act Now Because There Is A Limited Window of Time To Pursue A Legal Case

There is a very small window of time for victims to seek financial compensation — it is called the “statute of limitations” and the time window for pursuing a case is different in each state.

So please do not wait to speak to an attorney because you do not want to miss your opportunity to pursue a Taxotere® settlement or lawsuit.

Here is how to get started:

Fill out the free consultation form below and one of our attorneys will promptly call you to discuss your case.

This consultation is FREE. There is no-risk and absolutely no obligation. This is simply your opportunity to understand if you have a case and what the process is for pursuing financial compensation.

Abilify®

Abilify®

Abilify Can Result in Compulsive Gambling

Abilify patients who suffered losses as a result of compulsive behaviors have filed lawsuits against drug maker Bristol-Myer Squibb. They may be able to recover compensation for financial losses, neuropsychiatric injury, and other damages.

The lawsuit involving Abilify states the manufacturers of the prescription medication failed to warn doctors and patients that the drug could cause compulsive behavior, especially involving gambling, shopping, eating and sex.

Abilify Can Result in Compulsive Gambling

Abilify patients who suffered losses as a result of compulsive behaviors have filed lawsuits against drug maker Bristol-Myer Squibb. They may be able to recover compensation for financial losses, neuropsychiatric injury, and other damages.

The lawsuit involving Abilify states the manufacturers of the prescription medication failed to warn doctors and patients that the drug could cause compulsive behavior, especially involving gambling, shopping, eating and sex.

What is the Purpose of Abilify?

Abilify is an anti-psychotic medication used in the treatment of schizophrenia, bipolar disorder, Tourette’s syndrome, autism and depression.

It’s intended to help decrease hallucinations, disorganized thinking, mood swings, depressive thoughts and tics. It’s not approved to treat symptoms related to dementia, and can increase the risk of death in patients suffering from dementia.

Nearly 26 million Americans suffer from Type II diabetes, and Invokana® has become a hugely popular drug prescribed to help regulate blood glucose levels. When the drug was approved by the FDA in 2013, federal regulators stipulated that Janssen complete five post-market studies in order to measure Invokana® side effects. The first users were thus essentially guinea pigs for this new drug, and many have suffered kidney impairment, ketoacidosis, heart attack or stroke as a result. Invokana® lawsuits aim to recover compensation for individuals and families who have suffered as a result of Invokana® side effects, stating the company knew but failed to warn consumers of the risks posed by the medication.

Call Goldberg Attorneys today for help

or fill out the contact form below.

or fill out the contact form below.

If you or a loved one experienced kidney failure, kidney impairment, cardiac problems, blood acid problems, or ketoacidosis, Goldberg Injury Attorneys believe you may have grounds to file an Invokana® injury lawsuit for damages, harm, or loss suffered as a result of a kidney problems or ketoacidosis. It is likely that the makers of Invokana® were aware of the risks of heart attack, kidney problems, and ketoacidosis, yet have continued to market their products widely. If you would like more information to see if you may be entitled to money damages, please contact Goldberg Attorneys, 800-600-6014.

Side Effects of Abilify:

Examples of these side effects that have led to the need for Abilify patient assistance have included:

  • Diabetes
  • Seizures
  • Depression
  • Suicidal thoughts
  • Death

If you or a loved one has used Abilify, please contact Goldberg Attorney’s, P.C. for more information or call 800-600-6014.

 

Government regulators warn consumers about Abilify 

On May 3, 2016, the Food and Drug Administration (FDA) warned that some people using the antipsychotic drug Abilify® have reported compulsive or uncontrollable urges to gamble, eat, shop, or have sex. [1] The FDA is requiring manufacturers to add new warnings about these compulsive behaviors to Abilify drug labels and patient Medication Guides. [2] In 2012, European regulators required the makers of Abilify to warn consumers about the risk of uncontrollable impulses to gamble while taking the drug. [3] Canadian regulators required a similar warning last year. [4] For some patients, the serious, harmful side effects of Abilify have led to large debt, family problems, job loss, and legal problems. Despite government warnings, cases and studies confirming these side effects continue to date.